[JANX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 2.01%
YoY- -475.57%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 2,845 1,813 2,365 1,589 1,616 1,159 482 225.55%
PBT -16,065 -16,696 -16,888 -13,410 -13,416 -10,766 -6,206 88.20%
Tax -4,805 -2,652 -373 -264 -74 137 46 -
NP -11,260 -14,044 -16,515 -13,146 -13,416 -10,766 -6,206 48.59%
Tax Rate - - - - - - - -
Total Cost 14,105 15,857 18,880 14,735 15,032 11,925 6,688 64.23%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -395.78 -774.63 -698.31 -827.31 -830.20 -928.90 -1,287.55 -54.35%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.27 -0.34 -0.40 -0.32 -0.33 -0.26 -0.62 -42.45%
EPS Diluted -0.27 -0.34 -0.40 -0.32 -0.33 -0.26 -0.62 -42.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.